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Abstract
Background: Itch-producing compounds stimulate receptors expressed on small diameter fibers that innervate the
skin. Many of the currently known pruritogen receptors are Gq Protein-Coupled Receptors (GqPCR), which activate
Protein Kinase C (PKC). Specific isoforms of PKC have been previously shown to perform selective functions;
however, the roles of PKC isoforms in regulating itch remain unclear. In this study, we investigated the novel PKC
isoform PKCδ as an intracellular modulator of itch signaling in response to histamine and the non-histaminergic
pruritogens chloroquine and β-alanine.
Results: Behavioral experiments indicate that PKCδ knock-out (KO) mice have a 40% reduction in histamine-induced
scratching when compared to their wild type littermates. On the other hand, there were no differences between the
two groups in scratching induced by the MRGPR agonists chloroquine or β-alanine. PKCδ was present in small diameter
dorsal root ganglion (DRG) neurons. Of PKCδ-expressing neurons, 55% also stained for the non-peptidergic marker IB4,
while a smaller percentage (15%) expressed the peptidergic marker CGRP. Twenty-nine percent of PKCδ-expressing
neurons also expressed TRPV1. Calcium imaging studies of acutely dissociated DRG neurons from PKCδ-KO mice show a
40% reduction in the total number of neurons responsive to histamine. In contrast, there was no difference in the
number of capsaicin-responsive neurons between KO and WT animals. Acute pharmacological inhibition of PKCδ with an
isoform-specific peptide inhibitor (δV1-1) also significantly reduced the number of histamine-responsive sensory neurons.
Conclusions: Our findings indicate that PKCδ plays a role in mediating histamine-induced itch, but may be dispensable
for chloroquine- and β-alanine-induced itch.
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Background
Itch, clinically known as pruritus, is an unpleasant sen-
sory and emotional experience that leads to the desire
to scratch [1,2]. Chronic itch can result in severe anx-
iety, self-mutilation, and impaired overall quality of
life that is comparable to chronic pain [3-5]. Several
histamine-dependent and histamine-independent itch
receptors have been recently identified; however, few
of the intracellular mediators downstream of these re-
ceptors have been characterized. Elucidating the intra-
cellular mediators that activate pruriceptors may
provide a new set of targets to aid in the generation of
more specific and efficacious treatments.
Intradermal histamine induces itch via direct activation
of the H1 histamine receptor, which is expressed in sen-
sory neurons [6-10]. Additionally, several subtypes of the
recently characterized class of Mas-related G protein-
coupled receptors (MRGPR) have been shown to respond
selectively to a variety of non-histaminergic, itch-producing
compounds. For example, MRGPRA3 is activated by the
anti-malarial drug chloroquine (CQ) [11,12], and β-alanine
induces itch by activating a subset of nonpeptidergic
MRGPRD-expressing sensory neurons [13,14].
A common property of many of the identified pruritogen
receptors, including the H1 histamine receptor (H1R),
MRGPRA3, and MRGPRD, is that they are Gq protein-
coupled receptors (GqPCRs) [10-12,14]. Canonically,
GqPCRs activate phospholipase C (PLC), which cleaves
phosphatidylinositol (PIP2) into inositoltriphosphate (IP3)
and diacylglycerol (DAG), resulting in release of intracellu-
lar calcium stores and activation of downstream targets.
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However, the itch-mediating factors downstream of PLC
are largely unknown [10,15]. Protein kinase C (PKC) is
coupled to the canonical GqPCR/PLC pathway via activa-
tion by DAG and/or calcium and therefore may play a role
in the signaling of itch.
A number of PKC isoforms are expressed in sensory neu-
rons [16-19]. One of these isoforms is PKCδ, a member of
the “novel” PKC isozymes, which depends on DAG but not
calcium for its activation. Previously, we demonstrated that
PKCδ is dispensable for withdrawal responses to acute
noxious mechanical and thermal stimuli [20]. However,
studies of H1R signaling in human aortic endothelial cells
and HeLa cells showed that PKCδ is phosphorylated in
response to histamine [21,22]. PKCδ also mediated
histamine-induced H1R mRNA upregulation and down-
stream activation of ERK1/2 and p38 [21,22]. These lines of
evidence suggest that PKCδ could play a specific role as an
intracellular modulator of itch in sensory neurons.
In this study, we tested the hypothesis that PKCδ con-
tributes to pruritogen-induced itch. We determined the
role of PKCδ in histaminergic and non-histaminergic
itch by examining scratching responses to histamine and
the non-histaminergic pruritogens chloroquine and β-
alanine, which activate separate pruriceptor subpopula-
tions. We characterized the distribution of PKCδ in
sensory neurons and show that both genetic deletion
and pharmacological inhibition of PKCδ significantly de-
crease the proportion of histamine-responsive neurons.
Results
PKCδ mediates histamine-induced itch
To determine if PKCδ plays a role in behavioral
responses to itch, we assessed scratching responses to
histamine and non-histaminergic pruritogens in PKCδ
knock-out mice (PKCδ-KO) and their wild type littermates.
Mice were injected intradermally at the nape of the neck
with one of three pruritogens: histamine (1 mg), chloro-
quine (CQ) (200 μg), or β-alanine (223 μg). PKCδ-KO mice
scratched significantly less than their wild type littermates
when injected with histamine (Figure 1A, p < 0.05). On the
other hand, chloroquine-induced scratching was not signifi-
cantly different betweenWTand PKCδ KOmice (Figure 1B,
p = 0.129). There was also no difference in the number of
scratch bouts induced by β-alanine (Figure 1C, p = 0.61).
These results indicate that PKCδ mediates histaminergic
itch, but is not necessary for non-histaminergic itch in-
duced by CQ and β-alanine.
PKCδ is preferentially expressed in small diameter
DRG neurons
PKCδ is expressed in a variety of tissues, including the
brain and peripheral nervous system [19,21,23-30]. To as-
sess whether PKCδ is localized to potential pruriceptive
sensory neurons, immunohistochemistry (IHC) was used
to characterize the distribution of PKCδ in dorsal root
ganglion (DRG) neurons. Antibody specificity was con-
firmed via western blot using PKCδ-KO DRG and spinal
cord tissue. No antibody staining was found correspond-
ing to the 78kD PKCδ band in PKCδ-KO DRG tissue
(Figure 2A). This was further confirmed by IHC of knock-
out and wild type DRG (Figure 2B). In wild type lumbar
DRG, PKCδ was expressed in 43.2% of total neurons la-
beled with βIII tubulin (567/1314 cells, n = 3 animals) and
PKCδ expression was predominantly restricted to small
diameter neurons (average diameter 23.3 ± 0.19 μm, min
11.6 μm, max 36.2 μm) (Figure 2C).
PKCδ is expressed in peptidergic and non-peptidergic
DRG neurons
We further characterized PKCδ expression in small diam-
eter DRG neurons by immunohistochemical analysis of
peptidergic and non-peptidergic markers. Of peptidergic
neurons identified by anti-Calcitonin Gene Related Pep-
tide (CGRP+) immunoreactivity, 26.8% expressed PKCδ,
while 14.7% of PKCδ-expressing neurons were CGRP-
positive (Table 1, Figure 3A-B). PKCδ was also expressed
in non-peptidergic neurons identified by isolectin B4 (IB4)
binding. Of IB4+ DRG neurons, 61.6% expressed PKCδ
and 55.0% of PKCδ+ neurons exhibited IB4 binding
(Table 1, Figure 3C-D). These findings indicate that PKCδ
is expressed in both peptidergic and non-peptidergic sen-
sory neurons, with greater expression overlap found with
non-peptidergic IB4+ neurons.
Behavioral and physiological studies have shown that
itch produced by histamine is largely dependent on the
non-specific cation channel transient receptor potential
vanilloid receptor 1 (TRPV1) [31-33]. Because PKC has
previously been demonstrated to modulate TRPV1 function
and may present one potential mechanism by which PKCδ
regulates itch, we determined the degree of overlap between
PKCδ and TRPV1 expression [34,35]. We first confirmed
the specificity of our antibody directed against TRPV1
using TRPV1 knockout mice (Figure 3E, inset). Our data
indicate that 29.1% of PKCδ-positive neurons were also
TRPV1-positive, and 48.9% of TRPV1-positive neurons also
expressed PKCδ, suggesting a potential functional relation-
ship between PKCδ and TRPV1 (Figure 3E-F; Table 1).
PKCδ-KO sensory neurons exhibit diminished responses
to histamine
PKCδ is expressed in the brain, spinal cord, and the per-
ipheral nervous system [30,36-39]. Therefore, global gen-
etic deletion of PKCδ in our knockout mice makes it
difficult to pinpoint where PKCδ functions to modulate
histamine-induced scratching. The expression of PKCδ in
small diameter sensory neurons suggests that it may medi-
ate histamine-evoked itch by signaling in nociceptive neu-
rons responsive to pruritic agents (i.e., pruriceptors). To
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determine if PKCδ directly modulates neuronal responses
to histamine, calcium imaging was performed on acutely
dissociated adult mouse DRG neurons (Figure 4A-B). Of
the total sensory neurons treated with histamine, 11.1% of
wild type neurons responded to bath application of
100 μM histamine (126/1137 total WT neurons, N = 5 an-
imals), but only 6.7% of PKCδ-KO neurons responded to
histamine (47/706 total KO neurons, N = 3 animals), indi-
cating a significant reduction of 39.6% in the proportion of
histamine responsive neurons (p < 0.01, χ2 test) (Figure 4C).
No significant difference in peak calcium responses to
histamine was detected between knock-out and wild type
cells (WT 33.6 ± 2.8% increase from baseline, n = 126 cells;
KO 39.9 ± 6.6% increase from baseline, n = 47 cells, un-
paired t-test, p = 0.304) (Figure 4D).
We hypothesized that PKCδ could contribute to neuronal
responses to histamine by mediating histamine receptor
coupling to TRPV1, or by regulating the normal expression
or function of TRPV1. To investigate whether the absence
of PKCδ affects the activation of TRPV1 within histamine-
responsive neurons, we applied the TRPV1-specific agonist
capsaicin after the histamine response. We found that
Figure 1 PKCδ-KO and WT scratching responses to pruritogens. A. PKCδ-KO mice scratched less than wild type littermates in response to
intradermal histamine injection (WT = 121.4 ± 12.8 scratch bouts/30 min, n = 25; KO = 73.8 ± 15.5 scratch bouts/30 min, n = 19; unpaired t test
p < 0.05). B. Chloroquine (CQ)-induced scratching was not different between PKCδ-KO and WT mice (WT = 163.7 ± 22.6 scratch bouts/30 min, n = 23;
KO = 118.0 ± 18.9 scratch bouts/30 min, n = 21; unpaired t test p = 0.129). C. Scratch bouts induced by β-alanine were also not different between
PKCδ-KO and WT mice (WT = 57.0 ± 10 scratch bouts/30 min, n = 6; KO = 48.8 ± 12.3 scratch bouts/30 min, n = 8; unpaired t test p = 0.61).
Figure 2 Immunological analyses of PKCδ in the spinal cord and DRG. A. Western blot demonstrating expression of PKCδ in WT DRG and
spinal cord (SC) but not in PKCδ-KO tissue confirming the validity of the PKCδ antibody. B. Representative images of 18 μm sections from WT and
PKCδ-KO lumbar DRG. (Scale bar = 50 μm) C. Histogram of cell diameter measurements of PKCδ+ and PKCδ- neurons illustrates the localization of
PKCδ to small and medium diameter soma.
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58.7% of WT histamine-responsive neurons subsequently
responded to capsaicin (74/126 total His+ neurons), while
only 40.4% of KO histamine-sensitive neurons responded
to capsaicin (19/47 total His+ neurons; p < 0.05, χ2 test)
(Figure 4E). To determine whether the functional expres-
sion of TRPV1 is altered in PKCδ-KO neurons, we tested
WT and KO sensory neurons for responses to capsaicin.
There were no differences in the total number of capsaicin-
responsive neurons between KO and WT groups (117/194
(60.3%) WT neurons, 144/259 (55.6%) KO neurons, p =
0.315, χ2 test, Figure 4F). Together, these data indicate that
the reduction in histamine responses is not due to altered
levels of TRPV1 receptors in the KO, and support the idea
that PKCδ could modulate TRPV1 downstream of hista-
mine receptor activation.
To further control for the possibility of developmental
effects or compensatory mechanisms that may occur with
congenital genetic deletion of PKCδ, we performed cal-
cium imaging experiments with the same experimental
design using acute pharmacological inhibition in wild type
DRG cultures. The δV1-1 peptide inhibitor has been
shown to inhibit PKCδ activation in vitro and in vivo by
competitively binding to receptor for activated C-kinase
(RACK) proteins, which confer PKC isoform substrate
specificity [28,40-43]. DRG neurons were incubated with
the peptide inhibitor δV1-1 for 30 minutes prior to re-
cording. Consistent with our findings in PKCδ-KO neu-
rons, there was a significant reduction in the total number
of histamine-responsive neurons treated with peptide in-
hibitor when compared to scramble peptide-treated con-
trol neurons (18.5% (75/405) of scramble-treated neurons
vs. 13.1% (69/527) of peptide-treated neurons, N = 4 ani-
mals, p < 0.05, χ2 test) (Figure 4G). Peak calcium responses
induced by histamine were not different between
inhibitor- and scramble-treated groups (inhibitor 33.23 ±
2.7% change from baseline, n = 69 cells; scramble 41.0 ±
3.7% change from baseline, n = 75 cells, p = 0.095, un-
paired t test) (Figure 4H).
Discussion
Pruritic stimuli can activate sensory neurons via specific
intracellular signaling cascades, which represent poten-
tial targets for anti-pruritics, but these cascades remain
poorly understood. Characterizing signaling components
is a significant challenge, in part because of the great di-
versity of recently identified pruritic receptors. Some re-
ceptors involved in pruritus are coupled to Gi/o cascades
such as the H4 histamine receptor, while others utilize
kinase signaling pathways like the TSLP/IL-7 receptors
[6,7,44,45]. However, the majority of identified pruritic
receptors, including the H1 receptor and the “orphan”
family of MRGPR receptors, are linked by a common
Table 1 Percent of DRG neurons in which PKCδ
colocalizes with other markers (mean ± SEM)
Marker % of PKCδ+ neurons
expressing marker
% of marker+ neurons
expressing PKCδ
CGRP 14.7 ± 2.5 26.8 ± 3.5
IB4 55.0 ± 3.0 61.6 ± 7.9
TRPV1 29.1 ± 2.2 48.9 ± 4.0
n = 3–4 mice per marker.
Figure 3 Localization of PKCδ and markers of peptidergic and non-peptidergic dorsal root ganglion neurons. A. Representative images
of CGRP+, PKCδ+, and co-expressing (Merge) DRG neurons. B. Graphical representation of total neurons counted and degree of overlap (n = number
of neurons). C, D. Representative images of IB4+, PKCδ+, and IB4+/PKCδ + neurons and illustration of overlap. E, F. Representative images of TRPV1+,
PKCδ+, and TRPV+/PKCδ + neurons and illustration of overlap. Inset demonstrates TRPV1 antibody stain in TRPV1-KO mice. (Scale bar = 50 μm;
Arrowheads indicate example cells that express both markers).
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Gαq signaling mechanism [10,46-49]. In this study we fo-
cused on a component downstream of the canonical Gαq
signaling pathway, the serine/threonine kinase PKC.
PKC isozymes are divided into three groups: classic (acti-
vated by DAG and Ca2+), novel (activated by DAG but not
Ca2+), and atypical (activated by neither DAG nor Ca2+)
[50,51]. Specific PKC isoforms have been shown to select-
ively regulate nociceptive behavior and nociceptor physi-
ology [16,17,19,52-58]. We previously showed that the
novel isozyme PKCδ is dispensable for acute mechanical
and thermal nociceptive behaviors [20]. Previous reports
have implicated PKCδ in H1R signaling in non-neuronal
cells [21,22], but the specific role of PKCδ in pruriceptor
signaling and itch had not been explored. In this study we
found that PKCδ was necessary for the full expression of
histamine-induced itch, but it did not have significant ef-
fects on histamine-independent itch produced by the
MRGPR ligands chloroquine or β-alanine.
To determine whether the scratching deficit we observed
in PKCδ null mice could be attributed to loss of function
within sensory neurons, we examined anti-PKCδ staining
in mouse lumbar DRG. Previous studies indicated that
PKCδ is expressed in murine spinal cord and DRG, but the
precise subset of PKCδ-positive neurons had not been
characterized [30,36-39]. We found that PKCδ expression
was restricted to small diameter dorsal root ganglion neu-
rons. Furthermore, although PKCδ was expressed in both
peptidergic and non-peptidergic sensory neurons, it was
Figure 4 PKCδ mediates sensory neuron responses to histamine. A. Representative image of dissociated DRG neurons loaded with Fura-2 AM.
B. Representative traces of selected cells (corresponding colored circles in A in response to histamine, capsaicin, and KCl. C. Proportion of total
histamine responders in WT and KO DRG neurons (WT = 11.1% (126/1137 total WT neurons); KO = 6.7% (47/706 total KO neurons); **p < 0.01, χ2 test).
D. Peak calcium increase in response to histamine, defined as % signal increase above baseline. WT 33.6 ± 2.8% change from baseline, n = 126 cells; KO
39.9 ± 6.6% change from baseline, n = 47 cells, unpaired t-test, p = 0.304. E. Percent of histamine-responsive neurons that responded to capsaicin
(74/126 WT His + neurons; 19/47 KO His + neurons; p < 0.05, χ2 test). F. Proportion of capsaicin-responsive neurons (117/194 WT neurons, 144/259 KO
neurons, p = 0.315, χ2 test). G. Proportion of histamine-responsive neurons in scramble- vs. inhibitor-treated groups (18.5% (75/405) of scramble-treated
neurons vs. 13.1% (69/527) of peptide-treated neurons, p < 0.05, χ2 test). H. Peak calcium increase in response to histamine (inhibitor: 33.23 ± 2.7%
change from baseline, n = 69 cells; scramble: 41.0 ± 3.7% change from baseline, n = 75 cells, p = 0.095, unpaired t test).
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greatly enriched in the non-peptidergic subset. Both pepti-
dergic and nonpeptidergic fibers have been shown to play
a role in pruritus. Histaminergic itch is largely dependent
on CGRPα-positive neurons [59], however, a subset of
histamine-responsive neurons also express the nonpepti-
dergic marker IB4 [11,60].
Calcium imaging studies of dissociated DRG neurons
demonstrated that genetic deletion of PKCδ resulted in
a significant reduction of the proportion of adult sensory
neurons that were histamine-responsive. We further
confirmed these results using acute pharmacological in-
hibition, supporting the hypothesis that PKCδ functions
within normal wild type sensory neurons to mediate
acute histaminergic signaling. The expression of PKCδ
in small diameter sensory neurons, along with the reduc-
tion of histamine-responsive sensory neurons, suggest a
peripheral mechanism for the behavioral effects of global
PKCδ deletion on histamine-induced scratching.
Following histamine release, sensory neuron signaling
to produce itch is thought to depend on functional
coupling of H1R to TRPV1. Supporting this idea, mice
lacking TRPV1 exhibit greatly reduced scratching behav-
ior and cellular responses to histamine, and blocking
TRPV1 channel function likewise abolishes the response
of sensory neurons to histamine [31,33,61]. The mecha-
nisms by which H1R recruits TRPV1 are complex and
several different signaling pathways have been implicated
[32,33,62,63]. One possible mechanism by which hista-
mine could couple to TRPV1 in sensory neurons is
through PLC-induced PKC activation. This is further
supported by an expanding body of literature indicating
that PKC directly modulates TRPV1 function [34,35]. In-
deed, inhibitors for PLC and PKC prevent histamine-
induced TRPV1-potentiation [62]. We previously found
that acute mechanical and thermal pain were independ-
ent of PKCδ. In contrast, PKCδ was necessary for the
full expression of thermal hyperalgesia during Complete
Freund’s Adjuvant-induced inflammation, which is a
TRPV1 dependent process [20].
In this study, 49% of TRPV1-expressing neurons were
PKCδ-positive and we showed a significant reduction in
the proportion of capsaicin-responsive neurons within
the subset of neurons responsive to histamine. Addition-
ally, sensory neurons from PKCδ-KO mice not previ-
ously treated with histamine responded similarly to wild
type neurons when challenged with capsaicin. These ob-
servations indicate that acute detection of heat stimuli
by TRPV1 is not dependent on PKCδ, but suggest that
PKCδ could function downstream of the histamine re-
ceptor to modulate TRPV1 function. In further support
of this idea, several other inflammatory mediators in-
cluding PGE2, NGF, and IL-6 have been shown to acti-
vate PKCδ [39,64-66]. It is possible that pruritic
dermatoses marked by inflammation may recruit PKCδ,
resulting in sensory neuron modulation that could po-
tentiate itch.
In contrast to histaminergic signaling, the MRGPR re-
ceptors appear to produce their pruritic effects through
an alternative, PKCδ-independent pathway. Chloroquine
activates MRGRPA3 which couples to the irritant recep-
tor TRPA1 to produce itch. Neuronal responses to
chloroquine were prevented by inhibiting Gβγ subunit
activity, suggesting that the Gαq pathway is not necessary
for chloroquine-induced itch [15]. However, MRGPRA3
was also recently shown to sensitize TRPV1 via a PKC
mechanism likely dependent on Gαq signaling, suggest-
ing a possible mechanism for thermal sensitization [67].
This suggests that MRGPRA3 may have biased signaling
mechanisms that lead to itch and/or TRPV1-related
sensitization. Thus, the histamine receptor and MRGPRs
may share a pathway leading to sensitization of TRPV1
via PKC signaling, despite an alternative Gβγ mechanism
for MRGPRA3 signaling of itch [46,68].
In summary, we found that PKCδ is a mediator of his-
taminergic itch signaling in sensory neurons. Although
we specifically investigated PKCδ in this study, other
PKC isoforms may also be involved in modulating the
response to itch. For example, another novel PKC iso-
zyme, PKCε, is expressed in largely IB4+ neurons, and
has been shown to also modulate TRPV1 responses
[16,57,58,69]. The sensory neuron responses involved in
itch are complex, involving multiple molecular cascades
which may be differentially mediated by specific PKC
isoforms. Future studies that investigate the roles of
PKC isozymes in itch may contribute to better thera-
peutic specificity for the treatment of acute and chronic
pruritus.
Conclusions
Our studies indicate that PKCδ significantly contributes
to histamine-induced scratching behavior, but may be
dispensable for non-histaminergic itch induced by the
pruritogens chloroquine and β-alanine. In the peripheral
nervous system, PKCδ expression is restricted to small
diameter sensory neurons, and is found in both pepti-
dergic and nonpeptidergic neurons. Physiological studies
of cultured adult DRG demonstrate that PKCδ mediates
histamine-induced responses of sensory neurons using
genetic and pharmacological tools. In addition, PKCδ may
act downstream of the histamine receptor to modulate
TRPV1 activity. We conclude that PKCδ regulates sensory
neuron responses necessary for acute histaminergic itch,
and future studies should address the role of PKCδ in per-
sistent and inflammatory pruritic conditions. Because
PKCδ shows no effects on acute pain [20], but contributes
to histaminergic itch, PKCδ inhibition may be a potential
therapeutic target to selectively control pruritus.
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Methods
Subjects and ethical approval
All experiments were conducted in accordance with the
National Institute of Health guidelines and received the ap-
proval of the Animal Care and Use Committee of Washing-
ton University School of Medicine. 8–12 week old male
littermate mice were housed on a 12 hour light–dark cycle
and allowed ad libitum access to food and water.
PKCδ-KO mice were obtained from Dr. Michael
Leitges [70]. These mice were generated using a standard
gene targeting approach to insert a LacZ/neo cassette in
the first transcribed exon of the PKCδ gene to abolish
transcription, resulting in a global knock-out [70]. PKCδ-
KO mice were backcrossed on a C57BL/6 background for
at least 6 generations prior to use. PKCδ-KO mice were
then crossed with wild type C57BL/6 mice to generate
heterozygous mice, which were used to generate wild type
and KO littermates.
Pruritogen-induced scratching behavior
The nape of the neck and upper back were shaved with
electric clippers one day prior to behavioral experiments.
On the day of experiment, mice were placed in individ-
ual plexiglass observation boxes and allowed to accli-
mate in the presence of white noise for 2 hours. Using
gentle restraint, 50 μl consisting of pruritogen dis-
solved in 0.9% normal saline was injected intradermally
at the nape of the neck using a 29½ gauge insulin syr-
inge. The following pruritogen amounts were used:
1 mg histamine (Sigma Aldrich, St. Louis, MO), 200 μg
chloroquine (Sigma Aldrich, St. Louis, MO), and
223 μg β-alanine (Sigma Aldrich, St. Louis, MO). A
single scratch bout was defined as one or more rapid
back-and-forth motions of the hindpaw directed at the
injection site, ending with either a pause, licking, or
biting of the toes or placing of the hindpaw on the
floor. Scratch bouts by the hind-paw directed at the in-
jection site were counted over a period of 30 minutes.
Experimenters were blinded to mouse genotype.
PKCδ immunohistochemistry/Western Blotting protocol
For Western blotting, mice were euthanized by swift de-
capitation and lumbar spinal cord and lumbar DRG
were removed. Tissue samples were homogenized in
homogenization buffer (20 mM Tris–HCl, pH 7.4,
1 mM EDTA, 1 mM sodium pyrophosphate, 25 μg/ml
aprotinin, 25 μg/ml leupeptin and 100 μM phenyl-
methylsufonyl fluoride) on ice. 7 μg of spinal cord and
DRG protein were separated using 4-12% SDS-PAGE,
then transferred to nitrocellulose membrane. Membrane
was blocked in Odyssey blocking buffer for 1 hour, then
incubated in rabbit anti-PKCδ (1:1000, Santa Cruz) and
mouse anti-β-Tubulin (1:1000, Sigma-Aldrich) primary
antibodies in Odyssey buffer with 0.1% Tween-20 at 4°C
overnight. Blots were then washed in TBS-0.1% Tween-20,
and incubated for 1 hour at room temperature in secondary
antibodies (goat anti-rabbit Alexa Fluor 680 (1:20,000,
Sigma Aldrich); goat anti-mouse IR800 (1:20,000, Sigma
Aldrich)). Blots were washed and scanned using an Odyssey
infrared scanner.
For immunohistochemistry (IHC), mice were deeply
anesthetized with a ketamine, xylazine, and aceproma-
zine cocktail, then perfused intracardially with cold PBS
followed by 4% paraformaldehyde in PBS. Lumbar DRG
were removed and cryoprotected in 30% sucrose. Trans-
verse sections were cut at 18 μm thickness on a cryostat
and collected on slides. To determine the percentage of
total neurons that express PKCδ, dual labeling was per-
formed with rabbit anti-PKCδ (1:50, Santa Cruz) and
mouse anti-β-tubulin (1:1000, Sigma Aldrich) primary
antibodies. Briefly, sections were blocked in 2% BSA,
0.1% Milk powder, 0.05% Tween-20 TBS for 1 hr, then in-
cubated in primary antibodies overnight at 4°C. On day 2,
slides were washed and incubated in secondary antibodies
for 2–4 hours at 4°C (Alexa Fluor 488 Donkey anti-rabbit
1:200, Alexa Fluor 555 donkey anti-mouse 1:200, Invitro-
gen). Images were obtained using an upright epifluorescent
microscope (Nikon 80i, CoolSnapES camera). Labeled neu-
rons were counted in at least 3 randomly selected sections
separated by >50 μm per animal. The size distribution of
PKCδ+ neurons was determined using ImageJ software to
measure cell diameter. The percentage of PKCδ+ neurons
that also expressed CGRP or IB4 was determined using
dual labeling for PKCδ and CGRP (goat anti-CGRP 1:400,
Serotec) or Alexa-568 conjugated to IB4 (1:400, Invitrogen)
using the above-described procedures. PKCδ-TRPV1 coex-
pression was determined using a goat anti-PKCδ antibody
(1:50, Santa Cruz) and a rabbit antibody directed against
the TRPV1 C-terminus peptide (1:500) [34].
Calcium imaging
Scratching behavior was evoked with pruritic stimuli ap-
plied to the back skin where site directed scratching oc-
curs. We expanded our functional analyses of neuronal
physiology to include both thoracic and lumbar DRG.
Mice were euthanized rapidly by decapitation and DRG
removed and acutely dissociated using previously de-
scribed methods [71]. Briefly, DRG were incubated in
45U papain/L-cysteine in Hank’s buffered saline solution
(HBSS) without Ca2+ or Mg2+ and with 10 mM HEPES
for 20 minutes at 37°C and 5% CO2. Ganglia were then
washed, followed by 20 minute incubation in 1.5 mg/ml
collagenase in HBSS + HEPES. Ganglia were then tritu-
rated with fire-polished Pasteur pipettes, the dissociated
cells were filtered through a 40 μm cell strainer, and
were plated on poly-D-lysine and collagen-coated glass
coverslips. Cells were incubated overnight at 37°C in 5%
CO2 humidified air in culture medium (Neurobasal A
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with B27, pen/strep, 2 mM glutamax, 5% fetal bovine
serum (Gibco)). All experiments were performed within
24 hours of plating.
Cells were incubated in 3 μg/ml Fura-2 AM (Molecular
Probes) for 30 minutes and then incubated for 30 minutes
in external solution (in mM): 130 NaCl, 5 KCl, 2 CaCl2, 1
MgCl2, 30 Glucose, 10 HEPES. For each recording, a cover-
slip was placed in a perfusion chamber and perfused with
external solution at room temperature. Cells were viewed
under an inverted microscope (Olympus Optical, Tokyo,
Japan) and images were captured with a Hamamatsu Orca
camera. SimplePCI Software was used to draw regions of
interest (ROI) around Fura-loaded cells prior to recording.
The ratio of fluorescence emission at an excitation wave-
length of 357 and 380 nm was measured for each ROI.
The experimental protocol consisted of a 2 minute
baseline followed by 30 second bath application of his-
tamine (100 μM in external solution), >8 minutes of ex-
ternal solution wash, 10 second application of capsaicin
(200 nM), >8 minutes of external solution wash, and
10 seconds of KCl (50 mM) followed by wash (<2 mi-
nutes) to determine live neurons. A 10% or greater
change from baseline 357 nm/380 nm ratio was consid-
ered a response to histamine. Capsaicin experiments
were performed similarly except with 10 second capsa-
icin application (200nM). For experiments using PKCδ
peptide inhibitor and scrambled peptide, cells were
incubated in 100 μM peptide solution (dissolved in exter-
nal solution) for 30 minutes prior to recording (δV1-1
peptide inhibitor (Myr-SFNSYELGSL-NH2), peptide in-
hibitor scramble (Myr-GLSFSEYLSN-NH2), Biomatik).
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